Poughquag, NY, United States of America

Douglas Kamen

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Douglas Kamen: Innovator in Pharmaceutical Formulations

Introduction

Douglas Kamen, an accomplished inventor based in Poughquag, NY, has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, Kamen's work focuses on improving drug formulations and delivery methods, showcasing a commitment to innovation in healthcare.

Latest Patents

Two of Douglas Kamen's latest patents highlight his inventive prowess. The first patent involves "Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies." This invention comprises pharmaceutical formulations that include a human antibody specifically designed to bind to the human interleukin-6 receptor (hIL-6R). These formulations, which may also contain various amino acids, sugars, and non-ionic surfactants, demonstrate considerable stability after storage for extended periods, reinforcing their potential for clinical use.

The second patent relates to "Devices and methods for overfilling drug containers." This innovation outlines methods for overfilling primary packaging components, enabling the introduction of a greater volume of a formulated drug substance than the nominal volume of the packaging. This approach can notably enhance the efficiency of drug delivery systems, particularly with prefillable syringes.

Career Highlights

Douglas Kamen is currently affiliated with Regeneron Pharmaceuticals, Inc., a renowned biopharmaceutical company recognized for its impact on medical treatment and drug development. Kamen’s innovative contributions within the company underline the importance of pharmaceutical advancements that address critical health challenges.

Collaboration

In his journey at Regeneron, Kamen has collaborated with notable colleagues including Daniel B. Dix and Kenneth S. Graham. This teamwork exemplifies the collaborative spirit fostered within the company, driving forward the development of groundbreaking therapeutic solutions.

Conclusion

Douglas Kamen stands out as a prominent figure in the realm of pharmaceutical inventions, with his patents demonstrating a clear direction towards enhancing treatment options and drug stability. His work not only impacts the field of medicine but also paves the way for future innovations within the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…